Accelerate Diagnostics, Inc: Nasdaq/NYSE listing notice — Accelerate Diagnostics receives Nasdaq deficiency notice for bid price below $1.00

Accelerate Diagnostics, Inc

Deficiency letter received Jan 5, 2023; stock closed below $1.00 for 30 consecutive business days.
Must regain compliance by July 5, 2023; bid price must close at $1.00+ for 10 consecutive days.
If not compliant by deadline, may qualify for additional 180 days or face delisting.
Company evaluating options including a potential reverse stock split to cure deficiency.
No assurance that compliance will be regained or that any remedy will succeed.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Accelerate Diagnostics, Inc received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

January 5, 2023, Accelerate Diagnostics, Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued inclusion on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq rules, the Company has been provided an initial period of 180 calend

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001104659-23-003048

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.